K

Kangji Medical Holdings Ltd
HKEX:9997

Watchlist Manager
Kangji Medical Holdings Ltd
HKEX:9997
Watchlist
Price: 6.37 HKD -2.45% Market Closed
Market Cap: 7.5B HKD
Have any thoughts about
Kangji Medical Holdings Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one Kangji Medical Holdings Ltd stock under the Base Case scenario is 7.84 HKD. Compared to the current market price of 6.37 HKD, Kangji Medical Holdings Ltd is Undervalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
7.84 HKD
Undervaluation 19%
Relative Value
Price
K
Worst Case
Base Case
Best Case

Valuation Multiples

7.4
P/S
P/S
Price to Sales
7.4
vs History
54
vs Industry
18
Median 3Y
9.5
Median 5Y
7.8
Industry
2.3
Forward
6.7
More Details
13.6
P/E
P/E
Price to Earnings
13.6
vs History
52
vs Industry
37
Median 3Y
15.5
Median 5Y
13.4
Industry
23.1
Forward
12.4
More Details
15.4
P/OCF
P/OCF
Price to OCF
15.4
vs History
54
vs Industry
25
Median 3Y
19
Median 5Y
16.2
Industry
14.2
More Details
20
P/FCFE
P/FCFE
Price to FCFE
20
vs History
49
vs Industry
24
Median 3Y
24.1
Median 5Y
18.8
Industry
20.1
More Details
3.1
P/B
P/B
Price to Book Value
3.1
vs History
36
vs Industry
46
Median 3Y
2.5
Median 5Y
2.7
Industry
2.2
More Details
4.6
EV/S
EV/S
Enterprise Value to Sales
4.6
vs History
54
vs Industry
28
Median 3Y
5.6
Median 5Y
4.6
Industry
2.4
Forward
4.1
More Details
5.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.7
vs History
54
vs Industry
42
Median 3Y
7
Median 5Y
5.8
Industry
5
More Details
8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
8
vs History
54
vs Industry
40
Median 3Y
9.4
Median 5Y
7.8
Industry
12.7
Forward
6.3
More Details
8.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
8.4
vs History
54
vs Industry
41
Median 3Y
9.9
Median 5Y
8.3
Industry
17.1
Forward
6.9
More Details
9.5
EV/OCF
EV/OCF
Enterprise Value to OCF
9.5
vs History
54
vs Industry
38
Median 3Y
11.5
Median 5Y
9.7
Industry
14
More Details
12
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
12
vs History
52
vs Industry
31
Median 3Y
14.5
Median 5Y
11.3
Industry
18
More Details
2.9
EV/IC
EV/IC
Enterprise Value to IC
2.9
vs History
85
vs Industry
31
Median 3Y
4.5
Median 5Y
6.2
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Kangji Medical Holdings Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Kangji Medical Holdings Ltd
HKEX:9997
7.7B HKD 7.4 13.6 8 8.4
JP
Hoya Corp
TSE:7741
6.8T JPY 8.6 35.8 23.7 28.7
CH
Alcon AG
SIX:ALC
37.6B CHF 4.3 36.3 17.8 34.5
DK
Coloplast A/S
CSE:COLO B
179.6B DKK 6.6 35.6 22.9 26.9
US
Align Technology Inc
NASDAQ:ALGN
15.8B USD 4 35.7 18 21.7
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51.4B CNY 11.6 27.8 24.1 24.1
CA
Bausch + Lomb Corp
NYSE:BLCO
6.3B USD 1.4 -17.2 16.7 55.8
KR
HLB Inc
KOSDAQ:028300
9.1T KRW 175.4 -49 -75.4 -71.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.2B USD 4.1 14.5 10 11.3
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 2.6 37.2 264.5 462.1
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.7B USD 4.3 47.7 23.8 39
P/E Multiple
Earnings Growth P/E to Growth
CN
K
Kangji Medical Holdings Ltd
HKEX:9997
Average P/E: 31.6
13.6
58%
0.2
JP
Hoya Corp
TSE:7741
35.8
52%
0.7
CH
Alcon AG
SIX:ALC
36.3
107%
0.3
DK
Coloplast A/S
CSE:COLO B
35.6
50%
0.7
US
Align Technology Inc
NASDAQ:ALGN
35.7
102%
0.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.8
92%
0.3
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.2 N/A N/A
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -49 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
14.5
69%
0.2
UK
ConvaTec Group PLC
LSE:CTEC
37.2
208%
0.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
47.7
159%
0.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.